Humana (HUM) Valuation: Post-Earnings Miss and Guidance Cut
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Why Humana Stock’s 25% Rally Is Facing a Profit-Cut Reality Check
Humana cut its 2026 GAAP EPS forecast to at least $8.36, down from $8.89, but kept its adjusted profit outlook at $9.00. Shares last traded at $247.12, up over 25% in a month, pushing the price-to-earnings ratio to 26.4. First-quarter revenue rose to $39.65 billion, while adjusted EPS fell to $10.31. Medicare Advantage accounts for about 80% of Humana’s revenue. The post Why Humana Stock’s 25% Rally Is Facing a Profit-Cut Reality Check appeared …
Humana (HUM) Valuation: Post-Earnings Miss and Guidance Cut
Archyde Investors are currently grappling with a volatile period for Humana Inc. (HUM) as the healthcare giant navigates a challenging convergence of rising medical costs and regulatory pressure. The company recently ... Read More The post Humana (HUM) Valuation: Post-Earnings Miss and Guidance Cut appeared first on Archyde.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
